Motor Neuron Disease Clinical Trial
Official title:
Movement Related Cortical Potentials in Primary Lateral Sclerosis
This study will examine whether the motor cortex (the part of the brain that controls
movement) works properly in patients with primary lateral sclerosis (PLS), a disorder in
which voluntary movements are very slow.
Healthy volunteers between 40 and 75 years of age and patients with ascending PLS (a subset
of PLS) may be eligible for this study. Patients with ascending PLS have a slowing of
finger-tapping movements that corresponds to a particular abnormality of certain neuronal
(nerve cell) activity.
Participants perform a finger-tapping reaction time exercise while brain wave activity
(electroencephalography, or EEG) and muscle activity (electroymogram, or EMG) are measured.
The subject is seated in front of a computer screen. A signal appears on the screen and the
subject taps a key as quickly as possible in response to the signal.
For the EEG, brain activity is recorded by placing electrodes (small metal discs) on the
scalp with an electrode cap or glue-like substance. A conductive gel is used to fill the
space between the electrodes and the scalp to make sure there is good contact between them.
The brain waves are recorded while the subject taps his or her fingers very slowly. For the
surface EMG, electrodes filled with a conductive gel are taped to the skin.
Participants also undergo magnetic resonance imaging (MRI). This test uses a strong magnetic
field and radio waves to obtain images of the brain. During the procedure, the subject lies
still on a table that can slide in and out of the scanner - a narrow metal cylinder.
Scanning time varies from 20 minutes to 3 hours, with most scans lasting between 45 and 90
minutes. Subjects can communicate with the MRI staff at all times during the scan and can
ask to be moved out of the machine at any time.
Objective: Primary Lateral Sclerosis (PLS) is a clinical syndrome of progressive spasticity.
Patients with PLS have slow voluntary movements. In PLS, degeneration of corticospinal
tracts disrupts the communication between the motor cortex and motor neurons. Normally,
voluntary movements are preceded by EEG waveform changes that begin before the movement
occurs. These waveforms are called movement related cortical potentials (MRCPs). The first
part of the MRCP represents neural activity in the motor cortex. The goal of this study is
to determine whether the motor cortex and pre-motor cortex operate normally to generate
these intrinsic signals for voluntary movement in patients with PLS.
Study population: Patients with PLS of at least 3 years duration with slow finger tapping
movements will be studied. Patients must fulfill the clinical criteria for the ascending
subtype of PLS. They must also have a loss of corticospinal excitability as measured by
transcranial magnetic stimulation. Age matched normal volunteers will be studied as a
control group.
Design: Patients and normal volunteers will undergo a session of EEG recording while making
slow finger tapping movements. They will have an MRI of the brain, for the purpose of
localizing dipole positions of the MRCP components.
Outcome parameters: The peak amplitudes of components of the MRCPs will be compared between
patients and a healthy control group as the primary outcome measure. Localization of the
dipoles of the components is a secondary outcome measure.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04579666 -
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
|
Phase 2 | |
Completed |
NCT03706391 -
Study of ALS Reversals 4: LifeTime Exposures
|
||
Active, not recruiting |
NCT03067857 -
Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02464748 -
Telehealth in Motor Neurone Disease
|
N/A | |
Completed |
NCT00956488 -
Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis
|
Phase 1/Phase 2 | |
Terminated |
NCT00537446 -
Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis
|
N/A | |
Recruiting |
NCT04944940 -
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
|
||
Recruiting |
NCT03362658 -
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
|
||
Completed |
NCT00714636 -
Cerebrospinal Fluid Repository
|
N/A | |
Completed |
NCT00076687 -
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
|
Phase 2 | |
Completed |
NCT00001220 -
Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders
|
N/A | |
Completed |
NCT03487263 -
Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease
|
Phase 1 | |
Enrolling by invitation |
NCT05725759 -
Rehabilitation in SOD1 ALS Treated With Tofersen
|
||
Active, not recruiting |
NCT03811301 -
[BrainConnexion] - Neurodevice Phase I Trial
|
N/A | |
Completed |
NCT02469896 -
A Trial of Tocilizumab in ALS Subjects
|
Phase 2 | |
Completed |
NCT02011204 -
Study of Electrical Impedance Myography (EIM) in ALS
|
N/A | |
Completed |
NCT01495390 -
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
|
N/A | |
Completed |
NCT02870634 -
Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND
|
Phase 1 | |
Recruiting |
NCT06201650 -
Neurofilament Light Chain in Amyotrophic Lateral Sclerosis
|
||
Active, not recruiting |
NCT04240925 -
Tolerability, Safety and Efficacy of Sigh Breaths During NIMV in Motor Neuron Disease
|
N/A |